Imperial College London

ProfessorJaneDavies

Faculty of MedicineNational Heart & Lung Institute

Professor of Paediatric Respirology & Experimental Medicine
 
 
 
//

Contact

 

+44 (0)20 7594 7973j.c.davies

 
 
//

Assistant

 

Mrs Gina Rivellini +44 (0)20 7594 7986

 
//

Location

 

G44Emmanuel Kaye BuildingRoyal Brompton Campus

//

Summary

 

Publications

Citation

BibTex format

@article{De:2020:10.1016/j.jcf.2020.05.012,
author = {De, Boeck K and Lee, T and Amaral, M and Drevinek, P and Elborn, JS and Fajac, I and Kerem, E and Davies, JC},
doi = {10.1016/j.jcf.2020.05.012},
journal = {JOURNAL OF CYSTIC FIBROSIS},
pages = {688--695},
title = {Cystic fibrosis drug trial design in the era of CFTR modulators associated with substantial clinical benefit: stakeholders' consensus view},
url = {http://dx.doi.org/10.1016/j.jcf.2020.05.012},
volume = {19},
year = {2020}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AU - De,Boeck K
AU - Lee,T
AU - Amaral,M
AU - Drevinek,P
AU - Elborn,JS
AU - Fajac,I
AU - Kerem,E
AU - Davies,JC
DO - 10.1016/j.jcf.2020.05.012
EP - 695
PY - 2020///
SN - 1569-1993
SP - 688
TI - Cystic fibrosis drug trial design in the era of CFTR modulators associated with substantial clinical benefit: stakeholders' consensus view
T2 - JOURNAL OF CYSTIC FIBROSIS
UR - http://dx.doi.org/10.1016/j.jcf.2020.05.012
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000577562300008&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL - 19
ER -